BioTek, privately held and operared by the Alpert family for the past 50 years, has made public its agreement to be acquired by Agilent for roughly $1.16 billion. According to published reports, Agilent plans to have BioTek retain its name and remain in Vermont. The Winooski, Vermont site is expected to become a center of excellence for Agilent’s cell analysis division. This is good news for the roughly 300 people employed by the company in Vermont who are expected to keep their jobs after the acquisition closes later this year. Agilent was one of five bidders for BioTek which had initiated the search for a buyer earlier this year.  Learn More